Found 23 matching trials
Study of Velaglucerase Alfa Enzyme Replacement Therapy in Japanese Patients With Gaucher Disease
PHASE3Gaucher disease is an inherited deficiency of the lysosomal enzyme glucocer...
Location
Hamamatsu University School of Medicine
Long Term Impact of Rapid Intravenous Infusion of Velaglucerase Alfa (VPRIV)
PHASE4Background: In order to allow our satisfied patients, who have successfully...
Location
Multiple Locations
Home Therapy With VPRIV in Gaucher's Disease
N/AThe purpose of this study is to proof increasing patient satisfaction and p...
Location
Landeskrankenhaus Bregenz
A Study of VPRIV in Participants With Gaucher Disease Previously Treated With Other Enzyme Replacement Therapies or Substrate Reduction Therapies
N/AThe main aim of this study is to describe the safety profile of velaglucera...
Location
University of Alberta/Medical Genetics Clinic
Open-Label Extension Study Evaluating Long Term Safety in Patients With Type 1 Gaucher Disease Receiving DRX008A (ERT)
PHASE1Gaucher disease is a rare lysosomal storage disorder caused by the deficien...
Location
Shaare Zedek Medical Center
An Open-Label Extension Study of GA-GCB ERT in Patients With Type 1 Gaucher Disease
PHASE3The purpose of this study is to evaluate the long-term safety of every othe...
Location
Los Angeles Medical Center
Rapid Intravenous Infusion of Velaglucerase Alfa (VPRIV) in Treatment-naive Patients With Type 1 Gaucher Disease
PHASE4During the past two years, the investigator has performed succsefully an II...
Location
Michal Becker- Cohen
Study of Gene-Activated® Human Glucocerebrosidase (GA-GCB) ERT Compared With Imiglucerase in Type I Gaucher Disease
PHASE3Gaucher disease is a rare lysosomal storage disorder caused by the deficien...
Location
Duke Children's Hospital & Health Center
Study of the Effect of Velaglucerase Alfa (VPRIV®) on Bone-related Pathology in Treatment-naïve Participants With Type 1 Gaucher Disease
PHASE4The primary purpose of this study is to evaluate the effect of VPRIV therap...
Location
Cedars Sinai Medical Center
Post Marketing Surveillance (PMS) Study for Velaglucerase Alfa (VPRIV) in India
N/AThe main aim of this study is to measure the safety and to find out the eff...
Location
Amrita Institute of Medical Sciences & Research Centre (AIMS)